Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03993041 · ClinicalTrials.gov registry record · NA
Telehealth Psychotherapy for Depression in Parkinson's Disease
A NA study, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03993041 is a NA study that has completed, run by Boston University Charles River Campus. The registered enrollment target is 12 participants.
The verdict
NCT03993041, a NA study, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Depression is a prevalent non-motor symptom of Parkinson's disease (PD). Cognitive-behavioral therapy (CBT) has been shown to be an effective treatment for depression in PD. CBT is usually administered in-person in weekly sessions, but PD motor disability, stigma, and transportation issues may prevent attending such therapy sessions. CBT administered via live videoconference technology may allow the treatment of depression, while circumventing the barriers that deter those with PD from seeking psychological services. The investigators propose that videoconference CBT will improve mood in individuals with PD who have depression.
Interventions
- BEHAVIORAL Cognitive-behavioral therapy (CBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2021-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03993041
The ClinicalTrials.gov registry entry for NCT03993041 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive-behavioral therapy (CBT) is the first listed.
NCT03993041 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03993041 about?
NCT03993041 is a clinical study titled "Telehealth Psychotherapy for Depression in Parkinson's Disease". Depression is a prevalent non-motor symptom of Parkinson's disease (PD). Cognitive-behavioral therapy (CBT) has been shown to be an effective treatment for depression in PD. CBT is usually administered in-person in weekly sessions, but PD motor disability, stigma, and transportation issues may preve...
What is the current status of trial NCT03993041?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2019-08-01. Estimated completion is 2021-04-30.
What interventions are being tested in trial NCT03993041?
The interventions under investigation include: Cognitive-behavioral therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03993041?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.